An example of such an inhibitor used to treat brain tumor cells is NVP-BEZ235, an inhibitor of multiple targets that include ATM and DNA-PK catalytic subunit (DNA-PKcs), which was associated with the increased sensitivity of glioma stem cell xerographs in mice to RT and TMZ [71,105]. Here, ATM is linked to central nervous system cancer.